2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

被引：13

作者：

Li, Philip Kam-Tao ^{[1
]}

Bavanandan, Sunita ^{[2
]}

Mohamed, Rosmawati ^{[3
]}

Szeto, Cheuk-Chun ^{[1
]}

Wong, Vincent Wai-Sun ^{[4
,5
]}

Chow, Kai-Ming ^{[1
]}

Dan, Yock-Young ^{[6
]}

Huang, Chiu-Ching ^{[7
,8
]}

Lai, Ching-Lung ^{[9
,10
]}

Tanwandee, Tawesak ^{[11
]}

Teo, Boon Wee ^{[12
]}

Wong, Grace Lai-Hung ^{[4
,5
]}

Yeoh, Eng-Kiong ^{[13
]}

Iseki, Kunitoshi ^{[14
]}

Leung, Chi-Bon ^{[1
]}

Park, Hyeong Cheon ^{[15
]}

Kanjanabuch, Talerngsak ^{[16
,17
]}

Lu, Wanhong ^{[18
]}

Fung, James ^{[8
,9
,10
]}

Jia, Jidong ^{[19
]}

Kanda, Eiichiro ^{[20
]}

Law, Man-Ching ^{[1
]}

Liu, Hong ^{[21
]}

Loo, Ching-Kong ^{[22
]}

Mak, Siu-Ka ^{[22
]}

Lui, Sing-Leung ^{[23
]}

Tang, Hon-Lok ^{[24
]}

Wang, Angela Yee-Moon ^{[9
]}

Yu, Ming-Lung ^{[25
,26
]}

Cheung, Michael ^{[27
]}

Jadoul, Michel ^{[28
]}

机构：

[1] Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Prince Wales Hosp, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China

[2] Hosp Kuala Lumpur, Dept Nephrol, Kuala Lumpur, Malaysia

[3] Univ Malaysia, Dept Med, Fac Med, Kuala Lumpur, Malaysia

[4] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[5] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[6] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore

[7] China Med Univ & Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan

[8] China Med Univ & Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan

[9] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[10] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China

[11] Mahidol Univ, Div Gastroenterol & Hepatol, Siriraj Hosp, Dept Internal Med,Fac Med, Bangkok, Thailand

[12] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Nephrol, Singapore, Singapore

[13] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China

[14] Tomishiro Cent Hosp, Okinawa, Japan

[15] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea

[16] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand

[17] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[18] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nephrol, Coll Med, Xian, Peoples R China

[19] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[20] Kawasaki Med Sch, Dept Med Sci, Okayama, Japan

[21] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China

[22] Kwong Wah Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[23] Tung Wah Hosp, Dept Med, Hong Kong, Peoples R China

[24] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[25] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[26] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[27] Kidney Dis Improving Global Outcomes KDIGO, Brussels, Belgium

[28] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

来源：

KIDNEY INTERNATIONAL REPORTS | 2020年 / 5卷 / 08期

关键词：

chronic kidney disease; dialysis; direct-acting antiviral; infection control; kidney transplantation; VIRUS-INFECTION; MICRO-ELIMINATION; DIALYSIS PATIENTS; CORE ANTIGEN; HEMODIALYSIS; DACLATASVIR; ASUNAPREVIR; SAFETY; EFFICACY; THERAPY;

D O I：

10.1016/j.ekir.2020.05.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

引用

页码：1129 / 1138

页数：10

共 50 条

[41] The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
Levey, Andrew S.
de Jong, Paul E.
Coresh, Josef
El Nahas, Meguid
Astor, Brad C.
Matsushita, Kunihiro
Gansevoort, Ron T.
Kasiske, Bertram L.
Eckardt, Kai-Uwe
KIDNEY INTERNATIONAL, 2011, 80 (01) : 17 - 28
[42] Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving (KDIGO) Conference
Babitt, Jodie L.
Eisenga, Michele F.
Haase, Volker H.
Kshirsagar, Abhijit, V
Levin, Adeera
Locatelli, Francesco
Malyszko, Jolanta
Swinkels, Dorine W.
Tarng, Der-Cherng
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
Drueke, Tilman B.
KIDNEY INTERNATIONAL, 2021, 99 (06) : 1280 - 1295
[43] UPDATE OF HEPATITIS C THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
Tartara, Silvina G.
REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2017, 37 (03): : 172 - 182
[44] Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Perkovic, Vlado
Agarwal, Rajiv
Fioretto, Paola
Hemmelgarn, Brenda R.
Levin, Adeera
Thomas, Merlin C.
Wanner, Christoph
Kasiske, Bertram L.
Wheeler, David C.
Groop, Per-Henrik
KIDNEY INTERNATIONAL, 2016, 90 (06) : 1175 - 1183
[45] Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Josephson, Michelle A.
Becker, Yolanda
Budde, Klemens
Kasiske, Bertram L.
Kiberd, Bryce A.
Loupy, Alexandre
Malyszko, Jolanta
Mannon, Roslyn B.
Toenshoff, Burkhard
Cheung, Michael
Jadoul, Michel
Winkelmayer, Wolfgang C.
Zeier, Martin
KIDNEY INTERNATIONAL, 2023, 104 (06) : 1076 - 1091
[46] Disparate outcomes observed within Kidney Disease: Improving Global Outcomes (KDIGO) acute kidney injury stage 1
Sparrow, Harlan G.
Swan, Joshua T.
Moore, Linda W.
Gaber, A. Osama
Suki, Wadi N.
KIDNEY INTERNATIONAL, 2019, 95 (04) : 905 - 913
[47] Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Langman, Craig B.
Barshop, Bruce A.
Deschenes, Georges
Emma, Francesco
Goodyer, Paul
Lipkin, Graham
Midgley, Julian P.
Ottolenghi, Chris
Servais, Aude
Soliman, Neveen A.
Thoene, Jess G.
Levtchenko, Elena N.
KIDNEY INTERNATIONAL, 2016, 89 (06) : 1192 - 1203
[48] Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging
Bailey R.A.
Wang Y.
Zhu V.
Rupnow M.F.
BMC Research Notes, 7 (1)
[49] Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes
Rossato, Giovana
Tovo, Cristiane Valle
Lerias de Almeida, Paulo Roberto
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (01): : 25 - 29
[50] Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery
Birnie, Kate
Verheyden, Veerle
Pagano, Domenico
Bhabra, Moninder
Tilling, Kate
Sterne, Jonathan A.
Murphy, Gavin J.
CRITICAL CARE, 2014, 18 (06):

← 1 2 3 4 5 →